1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL HUMAN DRUGS FOR VETERINARY USE MARKET BY MEDICATION TYPE
5.1. Introduction
5.2. Antibiotics
5.3. Non-steroidal anti-inflammatories
5.4. Opioid pain relievers
5.5. Chemotherapeutics
5.6. Others
6. GLOBAL HUMAN DRUGS FOR VETERINARY USE MARKET BY DRUG TYPE
6.1. Introduction
6.2. Penicillin
6.3. Prednisone and Prednisolone
6.4. Diazepam
6.5. Prozac
6.6. Others
7. GLOBAL HUMAN DRUGS FOR VETERINARY USE MARKET BY ANIMAL TYPE
7.1. Introduction
7.2. Companion Animals
7.2.1. Cat
7.2.2. Dogs
7.3. Livestock Animals
7.3.1. Cattle
7.3.2. Swine
7.3.3. Poultry
7.3.4. Others
8. GLOBAL HUMAN DRUGS FOR VETERINARY USE MARKET BY ROUTE OF ADMINISTRATION
8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Topical
9. GLOBAL HUMAN DRUGS FOR VETERINARY USE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Spain
9.4.5. Others
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. Japan
9.6.2. China
9.6.3. India
9.6.4. South Korea
9.6.5. Taiwan
9.6.6. Thailand
9.6.7. Indonesia
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Merck & Co
11.2. Zoetis
11.3. Boehringer Ingelheim
11.4. Elanco Animal Health
11.5. Soparfin SCA
11.6. Ceva Sante Animale
11.7. Virbac S.A
12. RESEARCH METHODOLOGY
LIST OF FIGURES
LIST OF TABLES